Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

TDP-43 Depletion in Microglia Promotes Amyloid Clearance but Also Induces Synapse Loss.

Neuron | 2017

Microglia coordinate various functions in the central nervous system ranging from removing synaptic connections, to maintaining brain homeostasis by monitoring neuronal function, and clearing protein aggregates across the lifespan. Here we investigated whether increased microglial phagocytic activity that clears amyloid can also cause pathological synapse loss. We identified TDP-43, a DNA-RNA binding protein encoded by the Tardbp gene, as a strong regulator of microglial phagocytosis. Mice lacking TDP-43 in microglia exhibit reduced amyloid load in a model of Alzheimer's disease (AD) but at the same time display drastic synapse loss, even in the absence of amyloid. Clinical examination from TDP-43 pathology cases reveal a considerably reduced prevalence of AD and decreased amyloid pathology compared to age-matched healthy controls, confirming our experimental results. Overall, our data suggest that dysfunctional microglia might play a causative role in the pathogenesis of neurodegenerative disorders, critically modulating the early stages of cognitive decline.

Pubmed ID: 28669544 RIS Download

Associated grants

  • Agency: Wellcome Trust, United Kingdom
  • Agency: NIA NIH HHS, United States
    Id: P01 AG017586
  • Agency: NIA NIH HHS, United States
    Id: P30 AG010124
  • Agency: NINDS NIH HHS, United States
    Id: R01 NS095793

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


BioLegend (tool)

RRID:SCR_001134

Commercial antibody supplier and developer for biomedical research. These products are compatible with use in flow cytometry and mass cytometry, immunoprecipitation and chip, western blotting, immunofluorescence microscopy, and quantitative multiplexing.

View all literature mentions

Thermo Fisher Scientific (tool)

RRID:SCR_008452

Commercial vendor and service provider of laboratory reagents and antibodies. Supplier of scientific instrumentation, reagents and consumables, and software services.

View all literature mentions

Ambion Inc. (tool)

RRID:SCR_008406

A division of Applied Biosystems selling products for the isolation, detection, quantification, amplification, and characterization of RNA.

View all literature mentions

Jackson Laboratory (tool)

RRID:SCR_004633

An independent, nonprofit organization focused on mammalian genetics research to advance human health. Their mission is to discover the genetic basis for preventing, treating, and curing human disease, and to enable research for the global biomedical community. Jackson Laboratory breeds and manages colonies of mice as resources for other research institutions and laboratories, along with providing software and techniques. Jackson Lab also conducts genetic research and provides educational material for various educational levels.

View all literature mentions

Proteintech Group (tool)

RRID:SCR_008986

Proteintech Europe Ltd is an ISO 9001:2008 certified company

View all literature mentions

ACCORD (tool)

RRID:SCR_009015

Study testing whether strict glucose control lowers the risk of heart disease and stroke in adults with type 2 diabetes. In addition the study is exploring: 1) Whether in the context of good glycemic control the use of different lowering lipid drugs will further improve these outcomes and 2) If strict control of blood pressure will also have additional beneficial effects on reducing cardiovascular disease. The design was a randomized, multicenter, double 2 X 2 factorial trial in 10,251 patients with type 2 diabetes mellitus. It was designed to test the effects on major CVD events of intensive glycemia control, of fibrate treatment to increase HDL-cholesterol and lower triglycerides (in the context of good LDL-C and glycemia control), and of intensive blood pressure control (in the context of good glycemia control), each compared to an appropriate control. All 10,251 participants were in an overarching glycemia trial. In addition, one 2 X 2 trial addressed the lipid question in 5,518 of the participants and the other 2 X 2 trial addressed the blood pressure question in 4,733 of the participants. The glycemia trial was terminated early due to higher mortality in the intensive compared with the standard glycemia treatment strategies. The results were published in June 2008 (N Eng J Med 2008;358:2545-59). Study-delivered treatment for all ACCORD participants was stopped on June 30, 2009, and the participants were assisted as needed in transferring their care to a personal physician. The lipid and blood pressure results (as well as the microvascular outcomes and eye substudy results) were published in 2010. All participants are continuing to be followed in a non-treatment observational study.

View all literature mentions

Molecular Probes (tool)

RRID:SCR_013318

An Antibody supplier and subset of ThermoFisher Scientific which provides fluorescence reagents for various experiments and methods.

View all literature mentions

DSHB (tool)

RRID:SCR_013527

An antibody supplier which banks and distributes hybridomas and monoclonal antibodies for use in research. The bank includes antibodies against targets such as GFP, transcription factors, stem cells, and human.

View all literature mentions

HeLa (tool)

RRID:CVCL_0030

Cell line HeLa is a Cancer cell line with a species of origin Homo sapiens

View all literature mentions

C57BL/6J (tool)

RRID:IMSR_JAX:000664

Mus musculus with name C57BL/6J from IMSR.

View all literature mentions

VGLUT 1 Antibody (antibody)

RRID:AB_887879

This monoclonal targets VGLUT 1

View all literature mentions

CD68 (antibody)

RRID:AB_2074844

This monoclonal targets CD68

View all literature mentions

NAB228 (antibody)

RRID:AB_2314850

This unknown targets

View all literature mentions

CD68 antibody | FA-11 (antibody)

RRID:AB_322219

This monoclonal targets CD68

View all literature mentions

Alexa Fluor(R) 488 anti-beta-Amyloid, 1-16 (antibody)

RRID:AB_2564765

This monoclonal targets beta-Amyloid 1-16

View all literature mentions

Iba1 (antibody)

RRID:AB_2314667

This unknown targets

View all literature mentions

Synapsin 1 Polyclonal Antibody (antibody)

RRID:AB_2536207

This unknown targets Synapsin 1

View all literature mentions

Anti-Post Synaptic Density Protein 95, clone 6G6-1C9 (antibody)

RRID:AB_2092365

This monoclonal targets Post Synaptic Density Protein 95 (PSD-95)

View all literature mentions

TDP-43 antibody (antibody)

RRID:AB_615042

This polyclonal targets TDP-43

View all literature mentions

B6(SJL)-Tardbptm1.1Pcw/J (organism)

RRID:IMSR_JAX:017591

Mus musculus with name B6(SJL)-Tardbptm1.1Pcw/J from IMSR.

View all literature mentions

STOCK Tg(Thy1-EGFP)MJrs/J (organism)

RRID:IMSR_JAX:007788

Mus musculus with name STOCK Tg(Thy1-EGFP)MJrs/J from IMSR.

View all literature mentions

B6.129P2(Cg)-Cx3cr1tm2.1(cre/ERT2)Litt/WganJ (organism)

RRID:IMSR_JAX:021160

Mus musculus with name B6.129P2(Cg)-Cx3cr1tm2.1(cre/ERT2)Litt/WganJ from IMSR.

View all literature mentions

GraphPad Prism (software resource)

RRID:SCR_002798

Statistical analysis software that combines scientific graphing, comprehensive curve fitting (nonlinear regression), understandable statistics, and data organization. Designed for biological research applications in pharmacology, physiology, and other biological fields for data analysis, hypothesis testing, and modeling.

View all literature mentions

ImageJ (software resource)

RRID:SCR_003070

Open source Java based image processing software program designed for scientific multidimensional images. ImageJ has been transformed to ImageJ2 application to improve data engine to be sufficient to analyze modern datasets.

View all literature mentions

Imaris (software resource)

RRID:SCR_007370

Imaris provides range of capabilities for working with three dimensional images. Uses flexible editing and processing functions, such as interactive surface rendering and object slicing capabilities. And output to standard TIFF, Quicktime and AVI formats. Imaris accepts virtually all image formats that are used in confocal microscopy and many of those used in wide-field image acquisition.

View all literature mentions

BV-2 (cell line)

RRID:CVCL_0182

Cell line BV-2 is a Transformed cell line with a species of origin Mus musculus (Mouse)

View all literature mentions

B6(SJL)-Tardbptm1.1Pcw/J (organism)

RRID:IMSR_JAX:017591

Mus musculus with name B6(SJL)-Tardbptm1.1Pcw/J from IMSR.

View all literature mentions

B6(SJL)-Tardbptm1.1Pcw/J (organism)

RRID:IMSR_JAX:017591

Mus musculus with name B6(SJL)-Tardbptm1.1Pcw/J from IMSR.

View all literature mentions